Hexa Reports Industry Pneumonia Therapeutics Market

Pneumonia Therapeutics Market Share, Trends, Revenue and Key
Consumer by End User to 2025
“The global pneumonia therapeutics market is expected to reach USD 22.9
billion by 2025, according to a new report by Hexa Reports. This market is
anticipated to grow at an unprecedented rate owing to the increasing
prevalence of pneumococcal disease globally.”
The Global Pneumonia Therapeutics Market is expected to reach USD 22.9 billion by 2025, according to a new
report by Hexa Reports. This market is anticipated to grow at an unprecedented rate owing to the increasing
prevalence of pneumococcal disease globally. The increasing demand for pneumonia therapeutics is a result of
unmet clinical needs in emerging as well as developed regions. Increasing focus of healthcare organizations on
raising awareness and issuing guidelines for efficient management of pneumococcal disease is predicted to
broaden the scope for growth over the coming years.For instance, Infectious Diseases Society of
America/American Thoracic Society has issued guidelines on the management of community-acquired
pneumonia.
According to a white paper released by American Academy of Family Physicians, adherence to these guidelines
has resulted in positive patient outcomes during the treatment of community-acquired bacterial pneumonia in
patients. Moreover, growing R&D activities in life sciences are anticipated to create positive impact on the
market over the coming years. Consequentially, increase in number of products, currently being reviewed
under clinical trials, is anticipated to fuel the overall growth.
Browse Detail Report With TOC @
https://www.hexareports.com/report/pneumonia-therapeutics-market
Follow Us: